Substance use: impact on adherence and HIV medical treatment.
about
Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject DrugsMedication adherence and HIV symptom distress in relation to panic disorder among HIV-positive adults managing opioid dependenceCombination prevention: new hope for stopping the epidemicA pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersHigh proportion of HIV serodiscordance among HIV-affected married couples in northern VietnamPatterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherenceFactors associated with treatment initiation for psychiatric and substance use disorders among persons with HIVAlcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.Psychosocial Syndemics are Additively Associated with Worse ART Adherence in HIV-Infected Individuals.Interventions for Enhancing Adherence to Antiretroviral Therapy (ART): A Systematic Review of High Quality StudiesDose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.Relative Efficiency of Field and Online Strategies in the Recruitment of HIV-Positive Men Who Have Sex With Men.Improving mental health among people living with HIV: a review of intervention trials in low- and middle-income countriesFactors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.Appearance concerns and psychological distress among HIV-infected individuals with injection drug use histories: prospective analysesDirectly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance.The cost and intensity of behavioral interventions to promote HIV treatment for prevention among HIV-positive men who have sex with men.Cocaine Use May be Associated with Increased Depression in Persons Infected with HIV.Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study.Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatmentThe aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individualsAggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.Understanding Patterns Of High-Cost Health Care Use Across Different Substance User Groups.Recent Tobacco Smoking is Associated with Poor HIV Medical Outcomes Among HIV-Infected Individuals in New York.Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.Facilitators of HIV Medical Care Engagement Among Former Prisoners.Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San FranciscoThe role of disparities and socioeconomic factors in access to kidney transplantation and its outcome.Understanding interactions of formerly incarcerated HIV-positive men and transgender women with substance use treatment, medical, and criminal justice systems.The role of pain in quitting among human immunodeficiency virus (HIV)-positive smokers enrolled in a smoking cessation trial.HIV-infected individuals who use alcohol and other drugs, and virologic suppression.The impact of marijuana use on memory in HIV-infected patients: a comprehensive review of the HIV and marijuana literatures.Anxiety sensitivity and hazardous drinking among persons living with HIV/AIDS: An examination of the role of emotion dysregulation.Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire.Assessment of Sexual Dysfunction Symptoms in Female Drug Users: Standardized vs. Unstandardized Methods.The association between cigarette smoking, virologic suppression, and CD4+ lymphocyte count in HIV-Infected Russian women.Prevalence of Substance Use in an HIV Primary Care Safety Net Clinic: A Call for Screening.Correlates of recent HIV testing among substance-using men who have sex with men.
P2860
Q21284788-B2D01C42-93B9-4E2D-9870-DE5EF54653AAQ23914817-BE2AE8BC-507F-4062-9A69-36CB0A228BB2Q24630559-EB9573F1-7DC2-4186-BE68-9C7A0EF62CD3Q27000732-C6149169-9767-403E-8FA1-EC1D3CCF8E41Q28546629-35366BAD-EFDC-4331-9FF3-4DED15429808Q33637963-0FA20C28-4209-400A-9AE6-28099173882EQ33649034-80BA11CB-F765-4C6E-81EC-930C780ACC89Q33660210-6EBB7D01-62BC-4CCC-8337-4998E341CAD9Q33949899-C3851597-885F-48FA-B343-69AE3008B89EQ35513716-815EFB3D-C70A-4095-BB2D-7EC31854AB15Q35540603-81E27A70-50F2-44D2-B49A-B279A5AD6ED3Q35855263-58B49BE3-2AA3-48C3-9A19-6B53922F29A8Q35889811-4A151A5C-171B-489C-8C62-22ADC0A7A921Q36110015-A91D32BD-F5AE-4577-9364-A3B46E5A2C09Q36115179-CEA74989-BB34-41B8-8C42-18F5B6924A42Q36184648-D9F248AF-B0C8-4EC8-BE1C-6242237FB6EEQ36356751-0D8D37D9-1FA6-4CE4-AA32-A6F2195C7D6AQ36361975-E6C82673-719E-4EF7-9455-44D9CEDABD6DQ36586210-9364F521-4D91-4154-BB95-3CD792AD8D93Q36691614-B5E76EE8-494C-4915-B393-BE0863B0E7B3Q36784049-50E3E602-9DDA-420D-A293-7608E59FE261Q36810375-1CE01941-6B4C-436A-83D3-F66877AF9343Q36813501-21C09742-1666-4853-B86F-3CBC54B148F0Q36839084-DA2D6DEB-4E23-44C6-A47A-A958D9D9A246Q37074318-5035C025-EDD6-452D-8E5B-136E54912FDEQ37088838-9FEBC6C5-63A0-43ED-8D2D-24D5605EBEEBQ37102206-DA66568B-11D2-4BDA-B1AA-CCA0DC98DD68Q37478448-4CFE6197-A409-4B03-9A82-669E98673CA0Q37671714-D0CF7DD9-9741-410F-B451-13CE78D93495Q38225645-26CDA306-B88C-4D69-A4BD-C27C119907DBQ38627005-2A843372-E5B5-4B10-BC0E-F59C3903F7CEQ38741647-8644B1C4-0B3F-47E7-9769-9092A19B0F9DQ38781165-CA44A08C-8946-47B3-A8EB-B8E40B6391BFQ38823599-782988B2-8384-4D60-BF70-EFFFCA2ECFEFQ38920432-9F40579B-D001-4795-920C-D23EE6EECE3CQ39395715-8D1BEB8C-00B7-4646-ABCD-A5BA20F77D1EQ39984545-E2D67822-B2D6-4821-8E86-3F91D8E59F6BQ40204203-C87E4D3E-75D5-40AB-8E6F-A15B015DC9AEQ40344047-B71270B1-8F42-44FC-A05A-B0DBDE6399DFQ40746788-A254D3CB-F83E-44DB-A871-45758FA2C1B4
P2860
Substance use: impact on adherence and HIV medical treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Substance use: impact on adherence and HIV medical treatment.
@en
Substance use: impact on adherence and HIV medical treatment.
@nl
type
label
Substance use: impact on adherence and HIV medical treatment.
@en
Substance use: impact on adherence and HIV medical treatment.
@nl
prefLabel
Substance use: impact on adherence and HIV medical treatment.
@en
Substance use: impact on adherence and HIV medical treatment.
@nl
P2093
P2860
P1476
Substance use: impact on adherence and HIV medical treatment.
@en
P2093
Adam Gonzalez
Conall O'Cleirigh
Jennifer Barinas
P2860
P2888
P304
P356
10.1007/S11904-011-0093-5
P577
2011-12-01T00:00:00Z